Prevalensi Resistensi ARV Lini Pertama pada Pasien yang Menerima Pengobatan Haart di Klinik HIV RSUP Sanglah Bali Tahun 2014 - 2016
on
Authors:
Jessica Santosa, I Made Susila Utama
Abstract:
“HIV is a virus that weakens the immune system. HIV can be classified into two genotypes, namely HIV-1 and HIV-2. Genotyping ofHIV-1 can be classified into three groups: group M, N, and O. Therapy for patients with positive HIV today is HAART or Highly ActiveAntiretroviral Therapy at present has much-experienced resistance to first-line. This study is an observational study with a crosssectionalstudy to determine the prevalence of resistance to first-line ARV therapy. The research was conducted from September2014 until January 2016 at the HIV clinic Sanglah Hospital. The data collection is done with a short interview and filling thequestionnaire, as well as secondary data from medical records of patients. Of the 68 samples that follow this study, 9 (13.2%) ofwhom experienced resistance and undergoing treatment with second-line antiretroviral drugs.”
Keywords
Keyword Not Available
Downloads:
Download data is not yet available.
References
References Not Available
PDF:
https://jurnal.harianregional.com/eum/full-34590
Published
2017-10-02
How To Cite
SANTOSA, Jessica; SUSILA UTAMA, I Made. Prevalensi Resistensi ARV Lini Pertama pada Pasien yang Menerima Pengobatan Haart di Klinik HIV RSUP Sanglah Bali Tahun 2014 - 2016.E-Jurnal Medika Udayana, [S.l.], v. 6, n. 10, p. 42 - 44, oct. 2017. ISSN 2303-1395. Available at: https://jurnal.harianregional.com/eum/id-34590. Date accessed: 28 Aug. 2025.
Citation Format
ABNT, APA, BibTeX, CBE, EndNote - EndNote format (Macintosh & Windows), MLA, ProCite - RIS format (Macintosh & Windows), RefWorks, Reference Manager - RIS format (Windows only), Turabian
Issue
Vol 6 No 10 (2017): E-Jurnal Medika Udayana
Section
Articles
Copyright
This work is licensed under a Creative Commons Attribution 4.0 International License
Discussion and feedback